Treatment of Ascites in Cirrhosis

  • Paolo Gentilini
  • Giorgio La Villa
  • Vincenzo Casini Raggi
  • Antonio Dello Sbarba
  • Roberto Giulio Romanelli
  • Piero Ticali
  • Francesco Gambilonghi
  • Donato Riccardi
  • Massimo Pinzani
  • Giacomo Laffi

Summary

The authors discussed the principal criteria for a correct medical treatment of ascites in liver cirrhosis. A therapeutical approach to ascites, based on a standardized sequential or stepped-care treatment was then considered, together with the available strategies for the management of diuretic resistant ascites. Finally, preliminary data on the efficacy of albumin infusion in ascitic patients undergoing a diuretic treatment were reported.

Keywords

Cirrhotic Patient Atrial Natriuretic Peptide Transjugular Intrahepatic Portosystemic Shunt Loop Diuretic Aldosterone Antagonist 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ginès P, Quintero E, Arroyo V, Teres J, Bruguera M, Rimola A, Caballeria J, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987;7:122–128.PubMedCrossRefGoogle Scholar
  2. 2.
    Gentilini P, Laffi G, La Villa G, Romanelli RG, Buzzelli GP, Casini Raggi V, Melani L, et al. Long course and prognostic factors of virus-induced liver cirrhosis. 1996, submitted for publication.Google Scholar
  3. 3.
    Arroyo V, Ginès P, Planas R, Panes J, Rodès J. Management of patients with cirrhosis and ascites. Semin Liver Dis 1986;6:353–369.PubMedCrossRefGoogle Scholar
  4. 4.
    Gentilini P, Laffi G. Pathophysiology and treatment of ascites and the hepatorenal syndrome. Bailliere’s Clin Gastroenterol 1992;6(3):581–607.CrossRefGoogle Scholar
  5. 5.
    Shear L, Ching S, Gabuzda GJ. Compartimentalization of ascites and edema in patients with hepatic cirrhosis. Gastroenterology 1970;282:1391–1396.Google Scholar
  6. 6.
    Pockros PJ, Reynolds TB. Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema. Gastroenterology 1986;90:1827–1833.PubMedGoogle Scholar
  7. 7.
    Ring-Larsen H, Henriksen JH, Wilken C, Clausen J, Pals H, Christensen NJ. Diuretic treatment in decompensated cirrhosis and congestive heart failure: effects of posture. Br Med J 1986;292:1351–1353.CrossRefGoogle Scholar
  8. 8.
    Gentilini P, La Villa G, Laffi G, Buzzelli G, Pinzani M, Cominelli F, Moscarella S, Birardi A. Sodium retention in cirrhosis: aspects of pathophysiology and treatment. Front Gastrointest Res 1986;9:203–218.Google Scholar
  9. 9.
    Arroyo V, Epstein M, Gallus G, Gentilini P, Ring-Larsen H, Salerno F. Refractory ascites in cirrhosis: mechanism and treatment. Gastroenterol Int 1989;2:195–207.Google Scholar
  10. 10.
    Rocco VK, Ware AJ. Cirrhotic ascites. Pathophysiology, diagnosis, and management. Ann Int Med 1986;105:573–585.PubMedGoogle Scholar
  11. 11.
    Gentilini P. Hepatology Elsewere: spironolactone and canrenoate: different antialdosteronic diuretic agents. Hepatology 1991;13:999–1000.PubMedCrossRefGoogle Scholar
  12. 12.
    Perez Ayuso RM, Arroyo V, Planas R, Gaya J, Bory F, Rimola A, Rivera F, Rodès J. Randomized comparative study of efficacy of furosemide versus spironolactone in non- azotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-angiotensin-aldosterone-system. Gastroenterology 1983;84:961–968.Google Scholar
  13. 13.
    Bernardi M, Laffi G, Salvagnini M, Azzena G, Bonato S, Marra F, Trevisani F, et al. Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content. Liver 1993;13:156–162.PubMedGoogle Scholar
  14. 14.
    Weiner IM. Diuretics and other agents employed in the mobilization of edema fluid. In Gilman AG, Rail TW, Nies AS & Taylor P (eds): Goodman & Gilman’s The pharmachological basis of therapeutics, 8th edn, pp 713–731. New York: Pergamon Press, 1990.Google Scholar
  15. 15.
    Laffi G, La Villa G, Carloni V, Foschi M, Bartoletti L, Quartini M, Gentilini P. Loop diuretic therapy in liver cirrhosis with ascites. J Cardiovasc Pharmacol 1993;22(3): S51–S58.PubMedCrossRefGoogle Scholar
  16. 16.
    Lesne M. Comparison of the pharmacokinetics of torasemide and furosemide in healthy volunteers. Arzneimittelforschung 1988;38:160–163.PubMedGoogle Scholar
  17. 17.
    Laffi G, Marra F, Buzzelli GP, Azzena G, Meacci E, De Feo ML, La Villa G, Gentilini P. Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study. Hepatology 1991;13:1101–1105.PubMedCrossRefGoogle Scholar
  18. 18.
    Arroyo V, Ginès P, Gerbes AL, Dudley F J, Gentilini P, Laffi G, Reynolds TB, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996;23:164–176.PubMedCrossRefGoogle Scholar
  19. 19.
    Pinzani M, Daskalopoulos G, Laffi G, Gentilini P, Zipser RD. Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance. Gastroenterology 1987;92:294–298.PubMedGoogle Scholar
  20. 20.
    Gentilini P, La Villa G, Marra F, Carloni V, Melani L, Foschi M, Quartini M, et al. Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites. J Hepatol 1996; in press.Google Scholar
  21. 21.
    Papadakis MA, Arieff AI. Unpredictability of clinical evaluation of renal function in cirrhosis. Am J Med 1987;82:945–952.PubMedCrossRefGoogle Scholar
  22. 22.
    Ginès P, Arroyo V, Quintero E, Planas R, Bory F, Cabrera J, Rimola A, et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology 1987;93: 234–241.Google Scholar
  23. 23.
    Ginès P, Arroyo V, Vargas V, Planas R, Casafont F, Panes J, Hoyos M, et al. Paracentesis with infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991;325:829–835.PubMedCrossRefGoogle Scholar
  24. 24.
    Wong F, Blendis L. Transjugular intrahepatic portosystemic shunt for refractory ascites: tipping the sodium balance. Hepatology 1995;22:358–364.PubMedCrossRefGoogle Scholar
  25. 25.
    Laffi G, Pinzani M, Meacci E, La Villa G, Renzi D, Baldi E, Cominelli F, et al. Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. Gastroenterology 1989;96:167–177.PubMedGoogle Scholar
  26. 26.
    Laffi G, Marra F, Pinzani M, Meacci E, Tosti-Guerra C, De Feo ML, Gentilini P. Effects of repeated atrial natriuretic peptide bolus injections in cirrhotic patients with refractory ascites. Liver 1989;9:315–321.PubMedGoogle Scholar
  27. 27.
    Laffi G, La Villa G, Gentilini P. Hepatorenal syndrome pathogenesis and treatment. Seminars in Liver Diseases 1994;14:71–81.CrossRefGoogle Scholar
  28. 28.
    Pinzani M, Laffi G, Meacci E, La Villa G, Cominelli F, Gentilini P: Intrarenal thromboxane A2 generation reduces the furosemide-induced sodium and water diuresis in cirrhosis with ascites. Gastroenterology 1988;95:1081–1087.PubMedGoogle Scholar
  29. 29.
    Gentilini P, Laffi G, Meacci E, La Villa G, Cominelli F, Pinzani M, Buzzelli G. Effects of OKY 046, a thromboxane synthase inhibitor, on renal function in non-azotemic cirrhotic patients with ascites. Gastroenterology 1988;94:1470–1477.PubMedGoogle Scholar
  30. 30.
    Laffi G, Marra F, Carloni V, Azzena G, De Feo ML, Pinzani M, Tosti-Guerra C, Gentilini P. Thromboxane receptor blockade increases water diuresis in cirrhotic patients with ascites. Gastroenterology 1992;103:1017–1021.PubMedGoogle Scholar
  31. 31.
    Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodès J. Peripheral vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151–1157.PubMedCrossRefGoogle Scholar
  32. 32.
    Moller S, Bendtsen F, Henriksen JH. Effects of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. Gastroenterology 1995;109:1927–1925.CrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Paolo Gentilini
    • 1
  • Giorgio La Villa
    • 1
  • Vincenzo Casini Raggi
    • 1
  • Antonio Dello Sbarba
    • 1
  • Roberto Giulio Romanelli
    • 1
  • Piero Ticali
    • 1
  • Francesco Gambilonghi
    • 1
  • Donato Riccardi
    • 1
  • Massimo Pinzani
  • Giacomo Laffi
    • 1
  1. 1.Istituto di Medicina Interna, Facolta’ di Medicina e ChirurgiaUniversita’ degli Studi di FirenzeFirenzeItaly

Personalised recommendations